IRIS OROZCO SANCHEZ: Open Payments
NPI 1679253421 · APOPKA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,846 in 56 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $630 · 2025 $1,846
Food & beverage: $1,846
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $815 |
| Janssen Biotech, Inc. | 11 | $250 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $232 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $146 |
| Celltrion USA Inc. | 1 | $133 |
| Novo Nordisk Inc | 1 | $76 |
| Madrigal Pharmaceuticals | 2 | $63 |
| Ipsen Biopharmaceuticals, Inc | 2 | $46 |
| Lilly USA, LLC | 2 | $40 |
| Regeneron Healthcare Solutions, Inc. | 1 | $30 |
Products named: CREON, TREMFYA, ENTYVIO, LINZESS, SKYRIZI, XIFAXAN, VEGZELMA, MAVYRET.
Industry payments across FL — which companies pay providers there.
